Astera Labs (ALAB) CFO awarded over 49,000 RSUs in stock grants

Q: How many Astera Labs (ALAB) RSUs were granted to the CFO in this filing?

The filing shows grants of 7,083 RSUs and 42,501 RSUs . Each RSU represents a contingent right to receive one share of Astera Labs common stock if vesting conditions tied to his continued service with the company are met.

Q: What is the vesting schedule for the 7,083 Astera Labs (ALAB) RSUs?

For the 7,083 RSUs , 25% vest on February 15, 2027 . The remaining RSUs then vest in 12 equal quarterly installments , provided Desmond Lynch maintains a continuous service relationship with Astera Labs through each scheduled vesting date.

Q: When do the 42,501 Astera Labs (ALAB) RSUs awarded to the CFO vest?

The 42,501 RSUs vest 100% on February 15, 2027 . This vesting is conditioned on the CFO’s continuous service with Astera Labs through that date, after which each vested RSU converts into one share of common stock.

Q: Did the Astera Labs (ALAB) CFO buy or sell shares in the market in this Form 4?

No. The transactions are coded as “A” grant/award acquisitions of RSUs with a price of $0.00 per share . They reflect stock-based compensation rather than open-market buying or selling activity by the Chief Financial Officer.

Q: What plan governs the RSU awards reported for Astera Labs (ALAB) CFO?

Both RSU awards were granted under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan . This plan provides for equity-based compensation, and the footnotes specify that each RSU represents a contingent right to receive one share of common stock upon vesting.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Lynch Desmond reported acquisition or exercise transactions in this Form 4 filing.

Astera Labs, Inc. Chief Financial Officer Desmond Lynch reported two equity awards of common stock. On May 1, 2026, he received grants classified as awards of restricted stock units (RSUs) under the company’s 2024 Stock Option and Incentive Plan.

One award for 7,083 RSUs vests 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments thereafter, subject to his continuous service. A second award for 42,501 RSUs vests 100% on February 15, 2027, also contingent on ongoing service. Each RSU represents the right to receive one share of Astera Labs common stock, and the transactions were recorded at a grant price of $0.00 per share, reflecting compensation rather than open-market buying.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Lynch Desmond

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	42,501	$0.00	--
Grant/Award	Common Stock	7,083	$0.00	--

Holdings After Transaction: Common Stock — 42,501 shares (Direct, null)

Footnotes (1)

These shares represent an award of restricted stock units ("RSUs") granted on May 1, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan (the "Plan"). Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These shares represent an award of RSUs granted on May 1, 2026 under the Plan. Such award provides that the RSUs shall vest as to 100% on February 15, 2027, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Key Figures

RSU grant 1: 7,083 RSUs RSU grant 2: 42,501 RSUs Vesting cliff date: February 15, 2027 +4 more

7 metrics

RSU grant 1 7,083 RSUs Award of restricted stock units granted May 1, 2026

RSU grant 2 42,501 RSUs Award of restricted stock units granted May 1, 2026

Vesting cliff date February 15, 2027 Initial vesting date for both RSU awards

Installment vesting 12 quarterly installments Remaining schedule after initial 25% vesting for 7,083 RSUs

Grant price $0.00 per share Reported transaction price for both RSU grants

Shares following transaction (line 1) 49,584 shares Total common stock reported after first RSU grant

Shares following transaction (line 2) 42,501 shares Total common stock reported after second RSU grant entry

Key Terms

restricted stock units ("RSUs"), Astera Labs, Inc. 2024 Stock Option and Incentive Plan, continuous service relationship, contingent right

4 terms

restricted stock units ("RSUs") financial

"These shares represent an award of restricted stock units ("RSUs") granted on May 1, 2026"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Astera Labs, Inc. 2024 Stock Option and Incentive Plan financial

"RSUs granted on May 1, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan"

continuous service relationship financial

"subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date"

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock"

Form 4 Insider Transactions: What Each Field Means →

05/05/2026 - 07:01 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lynch Desmond

(Last)

(First)

(Middle)

C/O ASTERA LABS, INC.

2345 NORTH FIRST STREET

(Street)

SAN JOSE

CALIFORNIA

95131

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		A		42,501⁽¹⁾	A	$0	42,501	D
Common Stock	05/01/2026		A		7,083⁽²⁾	A	$0	49,584	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These shares represent an award of restricted stock units ("RSUs") granted on May 1, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan (the "Plan"). Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

2. These shares represent an award of RSUs granted on May 1, 2026 under the Plan. Such award provides that the RSUs shall vest as to 100% on February 15, 2027, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Remarks:

	/s/ Philip Mazzara, Attorney-in-Fact	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Astera Labs (ALAB) CFO Desmond Lynch report in this Form 4?

He reported receiving two equity awards of Astera Labs common stock as restricted stock units (RSUs) on May 1, 2026. These are compensation-related grants, not open-market purchases or sales, and each RSU converts into one share upon vesting if he remains in service.

How many Astera Labs (ALAB) RSUs were granted to the CFO in this filing?

The filing shows grants of 7,083 RSUs and 42,501 RSUs. Each RSU represents a contingent right to receive one share of Astera Labs common stock if vesting conditions tied to his continued service with the company are met.

What is the vesting schedule for the 7,083 Astera Labs (ALAB) RSUs?

For the 7,083 RSUs, 25% vest on February 15, 2027. The remaining RSUs then vest in 12 equal quarterly installments, provided Desmond Lynch maintains a continuous service relationship with Astera Labs through each scheduled vesting date.

When do the 42,501 Astera Labs (ALAB) RSUs awarded to the CFO vest?

The 42,501 RSUs vest 100% on February 15, 2027. This vesting is conditioned on the CFO’s continuous service with Astera Labs through that date, after which each vested RSU converts into one share of common stock.

Did the Astera Labs (ALAB) CFO buy or sell shares in the market in this Form 4?

No. The transactions are coded as “A” grant/award acquisitions of RSUs with a price of $0.00 per share. They reflect stock-based compensation rather than open-market buying or selling activity by the Chief Financial Officer.

What plan governs the RSU awards reported for Astera Labs (ALAB) CFO?

Both RSU awards were granted under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. This plan provides for equity-based compensation, and the footnotes specify that each RSU represents a contingent right to receive one share of common stock upon vesting.